Clinical and epidemiologic features of SARS-CoV-2 in dogs and cats compiled through national surveillance in the United States
Journal of the American Veterinary Medical Association
; 261(4):480-489, 2023.
Artículo
en Inglés
| CAB Abstracts | ID: covidwho-20238711
ABSTRACT
OBJECTIVE:
To characterize clinical and epidemiologic features of SARS-CoV-2 in companion animals detected through both passive and active surveillance in the US. ANIMALS 204 companion animals (109 cats, 95 dogs) across 33 states with confirmed SARS-CoV-2 infections between March 2020 and December 2021. PROCEDURES Public health officials, animal health officials, and academic researchers investigating zoonotic SARS-CoV-2 transmission events reported clinical, laboratory, and epidemiologic information through a standardized One Health surveillance process developed by the CDC and partners.RESULTS:
Among dogs and cats identified through passive surveillance, 94% (n = 87) had reported exposure to a person with COVlD-19 before infection. Clinical signs of illness were present in 74% of pets identified through passive surveillance and 27% of pets identified through active surveillance. Duration of illness in pets averaged 15 days in cats and 12 days in dogs. The average time between human and pet onset of illness was 10 days. Viral nucleic acid was first detected at 3 days after exposure in both cats and dogs. Antibodies were detected starting 5 days after exposure, and titers were highest at 9 days in cats and 14 days in dogs. CLINICAL RELEVANCE Results of the present study supported that cats and dogs primarily become infected with SARS-CoV-2 following expo- sure to a person with COVID-19, most often their owners. Case investigation and surveillance that include both people and animals are necessary to understand transmission dynamics and viral evolution of zoonotic diseases like SARS-CoV-2.
Pets and Companion Animals [LL070]; Prion; Viral; Bacterial and Fungal Pathogens of Animals [LL821]; Diagnosis of Animal Diseases [LL886]; Prion; Viral; Bacterial and Fungal Pathogens of Humans [VV210]; Public Health Pests; Vectors and Intermediate Hosts [VV230]; antibodies; coronavirus disease 2019; diagnosis; disease prevalence; disease surveys; disease transmission; epidemiological surveys; epidemiology; human diseases; pandemics; pets; reservoir hosts; serological surveys; seroprevalence; viral diseases; zoonoses; hosts; cats; dogs; man; Severe acute respiratory syndrome coronavirus 2; USA; Felis; Felidae; Fissipeda; carnivores; mammals; vertebrates; Chordata; animals; eukaryotes; Canis; Canidae; Homo; Hominidae; primates; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; APEC countries; high income countries; North America; America; OECD Countries; very high Human Development Index countries; disease surveillance; pet animals; animal reservoirs; seroepidemiology; SARS-CoV-2; United States of America; viral infections; zoonotic infections
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
CAB Abstracts
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Idioma:
Inglés
Revista:
Journal of the American Veterinary Medical Association
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS